Muxu Zheng

Title: Muxu Zheng: Innovator in Colorectal Cancer Immunotherapy

Introduction

Muxu Zheng is a prominent inventor based in Guangdong, China. He has made significant contributions to the field of cancer research, particularly in the area of immunotherapy for colorectal cancer. His innovative work aims to enhance the efficacy of treatments for patients suffering from this challenging disease.

Latest Patents

Muxu Zheng holds a patent for a "System for predicting immunotherapeutic efficacy for colorectal cancer." This system performs several critical operations, including obtaining a digital image of biological tissue from a colorectal cancer patient. It predicts tissue type and cell type parameters using a classifier algorithm model. Additionally, it determines various cell feature parameters based on a calculating rule and calculates a therapeutic efficacy score. This score is designed to predict the therapeutic efficacy of immunotherapy for colorectal cancer patients. He has 1 patent to his name.

Career Highlights

Muxu Zheng is affiliated with the Sun Yat-sen University Cancer Center, where he conducts his research and development work. His role at this esteemed institution allows him to collaborate with other experts in the field and contribute to groundbreaking advancements in cancer treatment.

Collaborations

Muxu Zheng has worked alongside notable colleagues, including Peirong Ding and Wu Jiang. Their collaborative efforts have furthered the understanding and treatment of colorectal cancer, showcasing the importance of teamwork in scientific research.

Conclusion

Muxu Zheng's innovative contributions to colorectal cancer immunotherapy highlight his dedication to improving patient outcomes. His work exemplifies the potential of technology in transforming cancer treatment and underscores the importance of continued research in this vital area.